# Beta-blockers for Prevention of Supraventricular Arrhythmia Following PFO Closure

> **NCT07123506** · NA · NOT_YET_RECRUITING · sponsor: **Yonsei University** · enrollment: 350 (estimated)

## Conditions studied

- Atrial Fibrillation
- Atrial Flutter
- Tachycardia, Supraventricular
- Heart Septal Defects, Atrial

## Interventions

- **DRUG:** Beta-blocker treatment group
- **DRUG:** Non-treatment group

## Key facts

- **NCT ID:** NCT07123506
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2028-11-30
- **Final completion:** 2029-05-03
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2025-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07123506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07123506, "Beta-blockers for Prevention of Supraventricular Arrhythmia Following PFO Closure". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07123506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
